Stock listing
NASDAQ:MRSN Mersana Therapeutics Inc Stock
Follow Mersana Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:MRSN
$29.04 USD
Close on Jan 2, 2026 · No longer trades
- Lowest – highest close
- $5.97 – $29.10 USDSince Jul 28, 2025 · lowest Aug 11, 2025 · highest Dec 18, 2025
Delisted NASDAQ:MRSN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:MRSN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Mersana Therapeutics Inc on 6ix
- Calls
- 17 calls with a replay · 17 with a transcript · latest Aug 13, 2025
- Decks
- 6 decks · latest Aug 13, 2025
Events
| Call | When | Status |
|---|---|---|
| Mersana Therapeutics (MRSN) Q2 2025 Earnings Call | Wed, Aug 13, 2025 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q1 2025 Earnings Call | Thu, May 15, 2025 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q4 2024 Earnings Call | Mon, Mar 03, 2025 · 8:30 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q2 2024 Earnings Call | Tue, Aug 13, 2024 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q1 2024 Earnings Call | Thu, May 09, 2024 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q4 2023 Earnings Call | Wed, Feb 28, 2024 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q3 2023 Earnings Call | Tue, Nov 07, 2023 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q1 2023 Earnings Call | Tue, May 09, 2023 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q3 2022 Earnings Call | Mon, Nov 07, 2022 · 8:00 AM ET | Replay |
All 17 calls
| Call | When | Status |
|---|---|---|
| Mersana Therapeutics (MRSN) Q2 2022 Earnings Call | Mon, Aug 08, 2022 · 4:30 PM ET | Replay |
| Mersana Therapeutics (MRSN) Q1 2022 Earnings Call | Mon, May 09, 2022 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q4 2021 Earnings Call | Mon, Feb 28, 2022 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q3 2021 Earnings Call | Tue, Nov 09, 2021 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q2 2021 Earnings Call | Fri, Aug 06, 2021 · 8:00 AM ET | Replay |
| Mersana Therapeutics (MRSN) Q1 2021 Earnings Call | Mon, May 10, 2021 · 4:30 PM ET | Replay |
| Mersana Therapeutics (MRSN) Q4 2020 Earnings Call | Fri, Feb 26, 2021 · 8:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2025) | Investor deck | 35 slides | Aug 13, 2025 |
| Technical Presentation (January 2025) | Technical | 22 slides | Jan 10, 2025 |
| Technical Presentation (September 2021) | Technical | 32 slides | Sep 10, 2021 |
| Investor Day (January 2021) | Investor day | 53 slides | Jan 5, 2021 |
| Investor Presentation (January 2020) | Investor deck | 27 slides | Jan 10, 2020 |
| Investor Presentation (February 2019) | Investor deck | 24 slides | Feb 28, 2019 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Mott Other companies: Novavax, Inc. (Director · Since at least Jun 16, 2020); Ardelyx, Inc. (Chairman · Since at least Jun 18, 2014); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past); Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jul 1, 2024 · Past); Epizyme Inc (Director · May 30, 2013 – Aug 12, 2022 · Past); Omthera Pharmaceuticals Inc (Director · Apr 11, 2013 – Jul 18, 2013 · Past); Tesaro Inc (Director · Jun 27, 2012 – Jan 22, 2019 · Past); Medimmune Inc (Vice Chair. of the Board, CEO, Director · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Since at least Jun 27, 2017 |
| Andrew A F Hack Other companies: Nuvalent, Inc. (Director · Jul 28, 2021 – Dec 11, 2024 · Past); Atea Pharmaceuticals, Inc. (Director · Oct 29, 2020 – Nov 3, 2020 · Past); BCLS Acquisition Corp (Chief Financial Officer, Director · Oct 21, 2020 – Oct 26, 2020 · Past); Dynavax Technologies Corporation (Director · Aug 12, 2019 – Aug 8, 2023 · Past); Allena Pharmaceuticals Inc (Director · Jun 8, 2018 – Nov 17, 2020 · Past); Editas Medicine, Inc. (Chief Financial Officer · Feb 2, 2016 – Feb 4, 2019 · Past) | Director · Since at least Jun 27, 2017 |
| Lawrence M. Alleva Other companies: Galera Therapeutics, Inc. (Director · Since at least Nov 6, 2019); Bright Horizons Family Solutions Inc. (Board Member · Since at least May 12, 2016); Adaptimmune Therapeutics PLC (Chairman and Non-Executive Director · Since at least Jan 1, 2016); Tesaro Inc (Director · Jun 1, 2016 – Jan 22, 2019 · Past); Synlogic Inc (Director · Sep 30, 2015 – Jun 29, 2016 · Past) | Director · Since at least Sep 5, 2017 |
| Willard H. Dere Other companies: Metagenomi Therapeutics, Inc. (Professor Emeritus, Internal Medicine, University of Utah · Since at least Feb 8, 2024); Seres Therapeutics, Inc. (Director · Since at least Jul 7, 2017); BioMarin Pharmaceutical Inc. (Director · Since at least Jul 15, 2016); Ocera Therapeutics Inc (Director · Oct 26, 2016 – Dec 11, 2017 · Past); Radius Health, Inc. (Director · Nov 1, 2014 – Aug 15, 2022 · Past) | Director · Since at least Mar 19, 2018 |
| Anna Protopapas Other companies: Nuvalent, Inc. (Director · Since at least Mar 30, 2022); Dicerna Pharmaceuticals Inc (Director · Jan 23, 2019 – Jun 3, 2021 · Past); Bioverativ Inc (Director · Feb 28, 2017 – Mar 8, 2018 · Past); Ariad Pharmaceuticals Inc (Director · Feb 1, 2016 – Feb 16, 2017 · Past) | Director · Since at least Jun 27, 2017 |
| Elaine V. Jones Other companies: NextCure, Inc. (Director · Since at least May 8, 2019); CytomX Therapeutics, Inc. (Director · Since at least May 1, 2019); Ibere Pharmaceuticals (Director · Feb 25, 2021 – Feb 25, 2021 · Past); Gritstone bio, Inc. (Director · Sep 12, 2019 – Apr 4, 2025 · Past) | Director · Jun 27, 2017 – Jun 27, 2017 · Past |
| Kristen Hege Other companies: Adaptimmune Therapeutics PLC (Director · Nov 1, 2023 – Jul 1, 2024 · Past); LENZ Therapeutics, Inc. (Director · Jun 24, 2021 – Jul 19, 2023 · Past); Arcus Biosciences, Inc. (Director · Oct 19, 2018 – Jun 6, 2019 · Past); Cell Genesys Inc (VP Clinical Research · Feb 7, 2006 – Jul 31, 2008 · Past) | Director · Since at least Jun 27, 2017 |
| Alejandra Carvajal Other companies: CytomX Therapeutics, Inc. (Chief Legal Officer · Since at least Aug 3, 2026); Momenta Pharmaceuticals Inc (Chief Legal Officer · Oct 5, 2018 – Oct 1, 2020 · Past); Dare Bioscience, Inc. (VP, General Counsel · Jun 26, 2015 – Jan 5, 2017 · Past) | SVP, Chief Legal Officer · Since at least Apr 26, 2021 |
| Allene M Diaz Other companies: Ionis Pharmaceuticals, Inc. (Director · Since at least Jun 3, 2021); BCLS Acquisition Corp (Director · Oct 22, 2020 – Oct 22, 2020 · Past); Allena Pharmaceuticals Inc (Director · Apr 15, 2019 – Jun 3, 2021 · Past) | Director · Since at least Mar 9, 2021 |
| Martin H Huber Jr Other companies: Actuate Therapeutics, Inc. (Director · Since at least May 1, 2026); Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 15, 2021); Xilio Therapeutics, Inc. (PRESIDENT AND HEAD OF R&D · Oct 21, 2021 – Aug 16, 2023 · Past) | President, CEO, Director · Since at least Jan 15, 2021 |
All 21 people
| Person | Seat |
|---|---|
| Donald A Bergstrom Other companies: Relay Therapeutics, Inc. (President, R&D · Since at least Jul 15, 2020); Fusion Pharmaceuticals Inc (Director · Apr 1, 2021 – Jun 4, 2024 · Past) | Chief Medical Officer · Jun 27, 2017 – Feb 2, 2018 · Past |
| Sara M Nayeem Other companies: Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 29, 2021 · Past) | Director · Jun 27, 2017 – Jan 2, 2018 · Past |
| Wayne Foster Other companies: Atea Pharmaceuticals, Inc. (EXECUTIVE VP, Chief Accounting Officer · Since at least Oct 29, 2020) | Vice President of Finance · Jun 27, 2017 – Jan 23, 2019 · Past |
| Arvin Yang | SVP, Chief Medical Officer · Nov 30, 2020 – Jan 13, 2023 · Past |
| Ashish Mandelia | VP, Chief Accounting Officer · Since at least Jan 15, 2020 |
| Brian DeSchuytner | SVP, COO & CFO · Since at least Jan 15, 2021 |
| Eva M Jack | Chief Bus. Officer, Tres, Sec. · Jun 27, 2017 – Sep 14, 2020 · Past |
| Michael J Kaufman | Chief Manufacturing Officer · Jan 15, 2021 – Jul 15, 2021 · Past |
| Mohan Bala | SVP, Chief Development · Since at least Sep 5, 2023 |
| Timothy B Lowinger | SVP, Chief Sci.&Tech. Officer · Since at least Jun 27, 2017 |
| Tushar Misra | SVP, Chief Manuf. Officer · Aug 16, 2021 – Jan 13, 2024 · Past |
Log in to ask 6ix AI your own questions about Mersana Therapeutics Inc.